Research / TSLA / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-23-034847 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
9.22% · OPTIONAL · VALID
Capex intensity 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
10.54% · OPTIONAL · VALID
Operating cash generation 45th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.17% · OPTIONAL · VALID
Revenue growth 11th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
8.84% · CORE · VALID
Inventory pressure 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
58.76% · OPTIONAL · VALID
Gross margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
17.89% · CORE · VALID
Operating margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
7.55% · CORE · VALID
R&D intensity 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.97% · OPTIONAL · VALID
SBC intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.99% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Mar 31, 2019 0/9 normalized Level 3 Jun 30, 2019 0/9 normalized Level 3 Sep 30, 2019 0/9 normalized Level 3 Dec 31, 2019 0/9 normalized Level 3 Mar 31, 2020 7/9 normalized Level 3 Jun 30, 2020 7/9 normalized Level 3 Sep 30, 2020 8/9 normalized Level 3 Dec 31, 2020 8/9 normalized Level 3 Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Sep 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 2.02%
Current 9.22%
Delta 7.19% Capex Intensity Increased
Previous 8.26%
Current 10.54%
Delta 2.27% Cash Generation Increased
Previous 12.30%
Current 14.17%
Delta 1.87% Growth Decreased
Previous 47.20%
Current 8.84%
Delta -38.36% Inventory Pressure Increased
Previous 57.59%
Current 58.76%
Delta 1.17% Margin Decreased
Previous 18.19%
Current 17.89%
Delta -0.29% Profitability Decreased
Previous 9.62%
Current 7.55%
Delta -2.07% R And D Intensity Increased
Previous 3.78%
Current 4.97%
Delta 1.19% Sbc Intensity Increased
Previous 1.79%
Current 1.99%
Delta 0.21% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.